Skip to main content

Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States.

Publication ,  Journal Article
Goel, K; Vasudevan, L
Published in: Human vaccines & immunotherapeutics
December 2021

Currently in the United States, Human Papillomavirus (HPV) vaccination coverage among eligible individuals is lower compared to coverage goals of 80% set by the HealthyPeople 2030 initiative. In this study, we used the National Health and Nutrition Examination Survey (NHANES) 2015-2016 and 2017-2018 datasets to determine the association between HPV vaccine initiation among individuals of ages 9 to 26 years and their patterns of healthcare access and utilization. In particular, we examined the following healthcare characteristics: 1) having a routine place of healthcare, 2) having health insurance coverage, 3) frequency of healthcare visits per year, and 4) type of routine place of healthcare (outpatient primary care vs. ED, etc.). We fit independent multivariable logistic regression models for each NHANES dataset and controlled for sociodemographic characteristics and interactions with healthcare access and utilization characteristics. Our findings suggest that HPV vaccine initiation is positively associated with having a routine place of healthcare (2015-2016: aOR 1.92, 95% CI 1.25-2.95; 2017-2018: aOR 1.99, 95% CI 1.07-3.68). Relatedly, HPV vaccine initiation is negatively associated with never having received healthcare in the past year (2015-2016: aOR 0.61, 95% CI 0.41-0.90; 2017-2018: aOR 0.45, 95% CI 0.27-0.75). The results of this study suggest that interventions to promote HPV vaccination should include strategies that promote access to and utilization of routine health care services. Our findings are particularly salient in light of the drop in HPV vaccine initiation and healthcare access and utilization among adolescents during the COVID-19 pandemic.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Human vaccines & immunotherapeutics

DOI

EISSN

2164-554X

ISSN

2164-5515

Publication Date

December 2021

Volume

17

Issue

12

Start / End Page

5390 / 5396

Related Subject Headings

  • Young Adult
  • United States
  • SARS-CoV-2
  • Papillomavirus Vaccines
  • Papillomavirus Infections
  • Pandemics
  • Nutrition Surveys
  • Humans
  • Health Services Accessibility
  • Child
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Goel, K., & Vasudevan, L. (2021). Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States. Human Vaccines & Immunotherapeutics, 17(12), 5390–5396. https://doi.org/10.1080/21645515.2021.1989919
Goel, Kunal, and Lavanya Vasudevan. “Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States.Human Vaccines & Immunotherapeutics 17, no. 12 (December 2021): 5390–96. https://doi.org/10.1080/21645515.2021.1989919.
Goel K, Vasudevan L. Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States. Human vaccines & immunotherapeutics. 2021 Dec;17(12):5390–6.
Goel, Kunal, and Lavanya Vasudevan. “Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States.Human Vaccines & Immunotherapeutics, vol. 17, no. 12, Dec. 2021, pp. 5390–96. Epmc, doi:10.1080/21645515.2021.1989919.
Goel K, Vasudevan L. Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States. Human vaccines & immunotherapeutics. 2021 Dec;17(12):5390–5396.

Published In

Human vaccines & immunotherapeutics

DOI

EISSN

2164-554X

ISSN

2164-5515

Publication Date

December 2021

Volume

17

Issue

12

Start / End Page

5390 / 5396

Related Subject Headings

  • Young Adult
  • United States
  • SARS-CoV-2
  • Papillomavirus Vaccines
  • Papillomavirus Infections
  • Pandemics
  • Nutrition Surveys
  • Humans
  • Health Services Accessibility
  • Child